Shr loss 1.77 dlrs v profit 15 ct Net loss 8036000 v profit 576000 Sales 16.2 mln v 17.2 mln Avg shrs 4539437 v 3816580 1st half Shr loss 1.96 dlrs v profit 26 ct Net loss 8231000 v profit 996000 Sales 30.9 mln v 32.2 mln Avg shrs 4205707 v 3814141 NOTE: Current half net include 68000 dlr tax credit. Current net period include 6700000 dlr writedown inventory clinical chemistry products. Reuter 